A recent study assessed the clinical generalizability of FDA-approved AI-enabled medical devices. The investigation found that nearly one in four devices lacked clinical performance studies at the time of approval. The study emphasized the need for enhanced transparency and continuous monitoring to ensure safe and effective clinical integration of AI technologies.

Source: JAMA Network Open